These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21378277)

  • 1. Alantolactone inhibits cell proliferation by interrupting the interaction between Cripto-1 and activin receptor type II A in activin signaling pathway.
    Shi Y; Bao YL; Wu Y; Yu CL; Huang YX; Sun Y; Zheng LH; Li YX
    J Biomol Screen; 2011 Jun; 16(5):525-35. PubMed ID: 21378277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cripto forms a complex with activin and type II activin receptors and can block activin signaling.
    Gray PC; Harrison CA; Vale W
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5193-8. PubMed ID: 12682303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
    Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
    J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evolving web of signaling networks regulated by Cripto-1.
    Nagaoka T; Karasawa H; Castro NP; Rangel MC; Salomon DS; Bianco C
    Growth Factors; 2012 Feb; 30(1):13-21. PubMed ID: 22149969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal.
    Kelber JA; Shani G; Booker EC; Vale WW; Gray PC
    J Biol Chem; 2008 Feb; 283(8):4490-500. PubMed ID: 18089557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A compound-based computational approach for the accurate determination of hot spots.
    Wang L; Hou Y; Quan H; Xu W; Bao Y; Li Y; Fu Y; Zou S
    Protein Sci; 2013 Aug; 22(8):1060-70. PubMed ID: 23776011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of human ARIP2 and its relation to breast cancer.
    Li ZD; Wu Y; Bao YL; Yu CL; Guan LL; Wang YZ; Meng XY; Li YX
    Cytokine; 2009 May; 46(2):251-9. PubMed ID: 19349195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activin A, activin receptor type II, nodal, and cripto mRNA are expressed by eutopic and ectopic endometrium in women with ovarian endometriosis.
    Torres PB; Florio P; Galleri L; Reis FM; Borges LE; Petraglia F
    Reprod Sci; 2009 Aug; 16(8):727-33. PubMed ID: 19386982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel factors in regulation of activin signaling.
    Tsuchida K; Nakatani M; Matsuzaki T; Yamakawa N; Liu Z; Bao Y; Arai KY; Murakami T; Takehara Y; Kurisaki A; Sugino H
    Mol Cell Endocrinol; 2004 Oct; 225(1-2):1-8. PubMed ID: 15451561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms.
    Panopoulou E; Murphy C; Rasmussen H; Bagli E; Rofstad EK; Fotsis T
    Cancer Res; 2005 Mar; 65(5):1877-86. PubMed ID: 15753386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of activin, cripto, and follistatin in the endometrium of women with endometrioma.
    Rocha AL; Carrarelli P; Novembri R; Sabbioni L; Luisi S; Reis FM; Petraglia F
    Fertil Steril; 2011 Jun; 95(7):2241-6. PubMed ID: 21496809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
    Deacu E; Mori Y; Sato F; Yin J; Olaru A; Sterian A; Xu Y; Wang S; Schulmann K; Berki A; Kan T; Abraham JM; Meltzer SJ
    Cancer Res; 2004 Nov; 64(21):7690-6. PubMed ID: 15520171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling.
    Zheng H; Yang L; Kang Y; Chen M; Lin S; Xiang Y; Li C; Dai X; Huang X; Liang G; Zhao C
    Mol Carcinog; 2019 Apr; 58(4):565-576. PubMed ID: 30520143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The autocrine effect of activin A on human ovarian clear cell adenocarcinoma cells.
    Mabuchi Y; Yamoto M; Minami S; Umesaki N
    Oncol Rep; 2006 Aug; 16(2):373-9. PubMed ID: 16820918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activins and activin antagonists in the prostate and prostate cancer.
    Gold E; Risbridger G
    Mol Cell Endocrinol; 2012 Aug; 359(1-2):107-12. PubMed ID: 21787836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades.
    Wang X; Yu Z; Wang C; Cheng W; Tian X; Huo X; Wang Y; Sun C; Feng L; Xing J; Lan Y; Sun D; Hou Q; Zhang B; Ma X; Zhang B
    J Exp Clin Cancer Res; 2017 Jul; 36(1):93. PubMed ID: 28701209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways.
    Kelber JA; Panopoulos AD; Shani G; Booker EC; Belmonte JC; Vale WW; Gray PC
    Oncogene; 2009 Jun; 28(24):2324-36. PubMed ID: 19421146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alantolactone exhibits antiproliferative and apoptosis-promoting properties in colon cancer model via activation of the MAPK-JNK/c-Jun signaling pathway.
    Ren Y; Lv C; Zhang J; Zhang B; Yue B; Luo X; Yu Z; Wang H; Ren J; Wang Z; Dou W
    Mol Cell Biochem; 2021 Dec; 476(12):4387-4403. PubMed ID: 34460036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin.
    Jung BH; Beck SE; Cabral J; Chau E; Cabrera BL; Fiorino A; Smith EJ; Bocanegra M; Carethers JM
    Gastroenterology; 2007 Feb; 132(2):633-44. PubMed ID: 17258738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells.
    Parisi S; D'Andrea D; Lago CT; Adamson ED; Persico MG; Minchiotti G
    J Cell Biol; 2003 Oct; 163(2):303-14. PubMed ID: 14581455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.